Dr. Allison L. Agwu, MD, ScM, FAAP, FIDSA is Professor of pediatric and adult infectious diseases at the Johns Hopkins University School of Medicine. Her clinical interests include HIV/AIDS and infectious disease. Dr. Agwu earned her medical degree from the University of Maryland School of Medicine. She completed a residency in pediatrics and internal medicine at Case Western Reserve University (University Hospitals of Cleveland/ Rainbow Babies and Children’s Hospital), and a combined fellowship in pediatric and adult infectious diseases at the Johns Hopkins School of Medicine. Dr. Agwu's clinical and research interests focuses on children, adolescents, and young adults who are at-risk or living with HIV and their families. Clinically, she provides inpatient and outpatient pediatric infectious diseases' consultations and leads the Pediatric Adolescent HIV/AIDS Program, which provides multidisciplinary for those living with or affected by HIV. Further, she leads the young adult transition clinic, the Accessing Care Early (ACE) Clinic. Both programs are longstanding Ryan White Federal Grant-funded programs. Her overarching research goal is to decipher, address, and minimize disparities in treatment and outcomes for those living with HIV. Toward this goal, she oversees her own independent, longstanding, federally funded clinical research program and serves as principal investigator of the Johns Hopkins sites of the International Maternal, Pediatric, and Adolescent AIDS Clinical Trials (IMPAACT) Network and the Adolescent Trials' Network (ATN). Her research interests include optimizing outcomes for youth at-risk for and living with HIV, management and treatment strategies, and minimizing disparities in the use of antiretroviral therapy (ART) and outcomes. Other special interests include epidemiologic approaches to HIV, drug resistance, and clinical trials. She is a member of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. Dr. Agwu is Chair of the HIV Medicine Association. Dr. Agwu is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Gonorrhea, Chlamydia, and COVID-19.

Dr. Gregory M. Lucas is an associate professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include HIV/AIDS and infectious disease. Dr. Lucas received his undergraduate degree from the University of Notre Dame. He earned his M.D. from Duke University School of Medicine and his Ph.D. from Johns Hopkins. He completed his residency and performed a fellowship in infectious diseases at Johns Hopkins. He serves on the faculties of the Center for AIDS Research, where he is co-director of the Substance Use Scientific Working Group; the Center for Substance Abuse Treatment and Research; the Center for Adolescent Health; and the Heart and Vascular Institute. Dr. Lucas is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Hepatitis C, Myelitis, and AIDS Dementia Complex.

Dr. Kelly Gebo is a graduate of The Johns Hopkins University School of Medicine. She also earned an MPH in Epidemiology from The Johns Hopkins Bloomberg School of Public Health. She completed residency training in Internal Medicine at The Johns Hopkins Hospital followed by an infectious diseases fellowship and two additional years of fellowship training as a Robert Wood Johnson Clinical Scholar, also at Hopkins. Her clinical and research interests include clinical outcomes and healthcare utilization research within infectious diseases. She was Director of the JHU Public Health Studies Program between the Krieger School for Arts and Sciences and the Bloomberg School for Public Health, was an American Council of Education Fellow (hosted at the University of Pennsylvania) and was the inaugural Vice Provost for Education at Johns Hopkins. She was on sabbatical at Stanford University School of Medicine 2019-20 and served as the Chief Medical and Scientific Officer for the All of Us Research Program 2018-2020. She currently serves as the director of the Johns Hopkins Clinical Research Scholars Program and is Deputy Director of the Johns Hopkins Institute for Clinical and Translational Research. She has mentored undergraduate, public health and medical students, trainees, and junior faculty on infectious diseases and health services projects. She has authored or co-authored numerous chapters and over 250 papers. She is a member of the American Society of Clinical Investigation and has been awarded the David Levine Prize for mentoring at Johns Hopkins. LinkedIn https://www.linkedin.com/in/kelly-gebo-13377811/. Dr. Gebo is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Dr. Joel Blankson is an associate professor of medicine at the Johns Hopkins University School of Medicine. He also holds an appointment in molecular and comparative pathobiology. His areas of clinical expertise include HIV pathogenesis and infectious disease. Dr. Blankson earned his M.D. from Cornell University Medical College and his Ph.D. from Rockefeller University. He completed his residency and a fellowship in infectious disease at Johns Hopkins. His research interests include the natural control of HIV-1 infection. Dr. Blankson is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome.

Dr. Gregory Kirk is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in oncology and, at the Johns Hopkins Bloomberg School of Public Health, in epidemiology. His areas of clinical expertise include epidemiology, hepatitis, HIV, AIDS and infectious diseases. He serves as the vice chair for clinical and translational research at the Johns Hopkins School of Medicine. Dr. Kirk received his undergraduate degree from Oklahoma State University. He earned a Ph.D. and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He earned his M.D. from the University of Oklahoma Health Sciences Center College of Medicine. He completed a residency in preventative medicine at the Johns Hopkins Bloomberg School of Public Health and in internal medicine at Georgetown University. He performed a fellowship in infectious diseases at the National Institute of Allergy and Infectious Diseases. His research focuses on understanding and preventing the long-term consequences of chronic HIV infection, particularly the malignant complications of HIV and viral hepatitis. He has extensive research and clinical experience in Africa, leading the Gambia Liver Cancer Study, one of the largest studies of hepatocellular carcinoma (HCC) performed in the continent, in addition to years of collaborative research in Uganda. Dr. Kirk pioneered the use of elastography and application of novel aflatoxin-associated biomarkers of HCC risk to be applied in Consortium projects. He has strong, multidisciplinary team leadership skills as principal investigator of the ALIVE cohort and several other collaborative studies in Baltimore. Dr. Kirk is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, and Hepatitis B.

Dr. Yukari Manabe is a Professor in the Division of Infectious Diseases in the Department of Medicine with secondary appointments in the Bloomberg School of Public Health Department of International Health and the Department of Microbiology and Molecular Immunology. Dr. Manabe began her career working on the basic science aspects of tuberculosis (TB) immunopathogenesis in comparative animal models of infection, particularly latency, reactivation, and immune reconstitution inflammatory syndrome (IRIS) in the rabbit model within the Johns Hopkins Center for Tuberculosis Research. In 2007, she was seconded to the Infectious Diseases Institute (IDI) at Makerere College of Health Sciences as the Associate Medical Laboratory Director of the College of American Pathologists certified Makerere University-Johns Hopkins University Clinical Core Lab to study antiretroviral associated TB and IRIS. She then became the Head of Research at the IDI in 2008 until 2012 where she built research capacity and infrastructure to train Ugandan investigators. Since returning to Hopkins, she has become the PI of the Johns Hopkins POC STD Center (U54 funded through NIH) which is part of the newly formed Johns Hopkins Center for Innovative Diagnostics for Infectious Diseases. The Center develops new diagnostics, funds development for point-of-care diagnostics, evaluates (validation and verification) new technology, and performs pre-clinical studies to accelerate the development of infectious disease assays (STIs, TB, acute febrile illness, HIV, syphilis, viral hepatitis). Dr. Manabe is particularly interested in rapid, point-of-care infectious disease diagnostics suitable for the resource-limited settings particularly in sub-Saharan Africa (SSA). Her research has focused on accuracy testing of various rapid, point-of-care diagnostics for HIV and related infectious diseases of clinical importance in SSA. Studies have ranged from evaluations of performance accuracy through clinical implementation science studies on the patient-centered outcomes and impactful use of new rapid diagnostics. Dr. Manabe obtained her undergraduate degree from Yale University and her M.D. from Columbia University College of Physicians and Surgeons. After completing both her residency in Internal Medicine and fellowship in Infectious Diseases at Johns Hopkins Hospital, she joined the faculty in 1999. Dr. Manabe is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Cryptococcosis, Gonorrhea, Meningitis, and Tissue Biopsy.

Dr. Thomas Quinn is professor of medicine and pathology in the Johns Hopkins School of Medicine and professor of international health, epidemiology, and molecular microbiology and immunology in The Johns Hopkins School of Public Health, and professor of nursing in the Johns Hopkins School of Nursing. In 2006 he was appointed founding Director of the Johns Hopkins University Center for Global Health. He serves as advisor/consultant on HIV and STDs to the World Health Organization, Office of the Global AIDS Coordinator (PEPFAR), UNAIDS, and the FDA. He serves as Associate Director for International Research at the National Institute of Allergy and Infectious Diseases. He is a member of the Institute of Medicine of the National Academy of Sciences, and is a fellow of the American Association for the Advancement of Science. He is a fellow of the Infectious Diseases Society of America and a member of the American Association of Physicians. He is an author of over 900 publications on HIV, STDs, and infectious diseases, and serves on multiple editorial boards. Among his professional activities, Dr. Quinn is an alternate member of the Technical Panel of the Global Fund to Fight AIDS, Malaria, and Tuberculosis and has been on Advisor/Consultant on HIV and STDs to the World Health Organization, UNAIDS, and the U.S. Food and Drug Administration. In October 2004 he received membership in the Institute of Medicine. Dr. Quinn is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Genital Herpes, Chlamydia, and Human Papillomavirus Infection.

Dr. Trevor Crowell is an adjunct assistant professor at the Johns Hopkins University School of Medicine. His areas of clinical expertise include HIV/AIDS, sexually transmitted infections, and other infectious diseases. Dr. Crowell earned his M.D. from the University of Southern California Keck School of Medicine and his Ph.D. in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. He completed his residency at Case Western Reserve University/University Hospitals Case Medical Center and completed a fellowship in infectious diseases at Johns Hopkins. In addition to serving as a staff physician at Bayview Medical Center, Dr. Crowell is an Associate Director at the U.S. Military HIV Research Program, Walter Reed Army Institute of Research. He is also an assistant professor of medicine at the Uniformed Services University of the Health Sciences. Dr. Crowell is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Gonorrhea, Sepsis, and Chlamydia.

Dr. Deborah Persaud is a professor of pediatrics at the Johns Hopkins University School of Medicine, and the director of the Division of Pediatric Infectious Diseases at Johns Hopkins Children's Center. She holds joint appointments in international health and molecular microbiology and immunology at the Johns Hopkins Bloomberg School of Public Health. A clinician and researcher specializing in the study and treatment of HIV-1 infection in children, she directs the pediatric infectious diseases fellowship program at the Johns Hopkins Children’s Center. Dr. Persaud received her B.S. in chemistry from York College in New York. A 1985 graduate of the New York University School of Medicine, she trained in pediatrics at Babies Hospital/Columbia Presbyterian Medical Center in New York, where she was chief resident. She was an infectious disease fellow, an Aaron Diamond postdoctoral research fellow and a faculty member at New York University. She joined the Johns Hopkins faculty in 1997, following a visiting lectureship at the Moi University in Eldoret, Kenya. Her research interests include HIV/AIDS drug development and mother-to-child HIV transmission. Dr. Persaud is the scientific chair of the HIV CURE Scientific Committee of the International Maternal, Pediatric Adolescent AIDS Clinical Trials (IMPAACT) group. She was awarded the prestigious Elizabeth Glaser Scientist Award for her HIV research and was recognized by Nature magazine in 2013 as one of “Ten People Who Mattered This Year.” She was recognized by Time magazine as among the “100 Most Influential People of 2013” for her pediatric HIV treatment research. Dr. Persaud is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Sepsis, Multisystem Inflammatory Syndrome in Children (MIS-C), and Pneumocystis Jiroveci Pneumonia.

Dr. Joyce Leitch Jones is a faculty member at the Johns Hopkins University School of Medicine. Her area of clinical expertise is infectious diseases. Dr. Jones earned her M.D. at the University of Maryland School of Medicine. She completed her residency at Columbia University Medical Center and performed a fellowship in epidemiology at Weill Cornell Medical College. Dr. Jones is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome.

Dr. Eileen Scully is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. She is the Director of the Center for AIDS Research Clinical Core and the Co-Director of the Physician Scientist Pathway in the Osler Internal Medicine Residency program. She received her B.S. from the University of Notre Dame. She earned her Ph.D. in Immunobiology and M.D. from Yale University. She completed her residency at Brigham and Women’s Hospital and performed a fellowship in infectious diseases at Massachusetts General Hospital with specialty training in the care of HIV. Dr. Scully is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dementia Complex, AIDS Dysmorphic Syndrome, and Fasciotomy.

Jeremy Sugarman, MD, MPH, MA is the Harvey M. Meyerhoff Professor of Bioethics and Medicine, professor of medicine, professor of Health Policy and Management, and deputy director for medicine of the Berman Institute of Bioethics at the Johns Hopkins University. He is an internationally recognized leader in bioethics with particular expertise in applying empirical methods and evidence-based standards for evaluating and analyzing bioethical issues. His contributions to bioethics and policy include his work on the ethics of informed consent, umbilical cord blood banking, stem cell research, international HIV prevention research, global health and research oversight. Dr. Sugarman is the author of over 400 articles, reviews and book chapters. He has also edited or co-edited four books (Beyond Consent: Seeking Justice in Research; Ethics of Research with Human Subjects: Selected Policies and Resources; Ethics in Primary Care; and Methods in Medical Ethics). Dr. Sugarman is on the editorial boards of several academic journals. Dr. Sugarman consults and speaks internationally on a range of issues related to bioethics. He was senior policy and research analyst for the White House Advisory Committee on Human Radiation Experiments, consultant to the National Bioethics Advisory Commission, and Senior Advisor to the Presidential Commission for the Study of Bioethical Issues. He also served on the Maryland Stem Cell Research Commission. He was the founding director of the Trent Center for Bioethics, Humanities and History of Medicine at Duke University where he was also a professor of medicine and philosophy. He was appointed as an Academic Icon at the University of Malaya and is a faculty affiliate of the Kennedy Institute of Ethics at Georgetown University. Dr. Sugarman was the longstanding chair of the Ethics Working Group of the HIV Prevention Trials Network. He is currently a member of the Scientific and Research Advisory Board for the Canadian Blood Service and the Ethics and Public Policy Committees of the International Society for Stem Cell Research. He co-leads the Ethics and Regulatory Core of the NIH Pragmatic Trials Collaboratory and is co-chair of the Johns Hopkins’ Institutional Stem Cell Research Oversight Committee. Dr. Sugarman has been elected as a member of the American Society of Clinical Investigation, Association of American Physicians, and the National Academy of Medicine (formerly the Institute of Medicine). He is a fellow of the American Association for the Advancement of Science, the American College of Physicians and the Hastings Center. He also received a Doctor of Science, honoris causa, from New York Medical College. Dr. Sugarman is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Ventricular Fibrillation, Hepatitis, Hepatitis B, and Kidney Transplant.

Dr. Chloe Thio is a professor of medicine and an associate professor of molecular microbiology and immunology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include hepatitis, HIV/AIDS and infectious disease. Dr. Thio received her B.A. from the University of Pennsylvania. She earned her M.D. from the Yale University School of Medicine. She completed her residency at Hospital of the University of Pennsylvania and her fellowship in infectious diseases at Johns Hopkins. Her research interests include chronic hepatitis B and C and coinfection of viral hepatitis with HIV/AIDS. She has developed a program centered around virology and immunology translational work towards an HBV cure. Dr. Thio is a member of the American College of Physicians, the American Association for the Study of Liver Disease, the American Society of Clinical Investigation, HIVMA and the Infectious Diseases Society of America. Dr. Thio is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are Hepatitis, Hepatitis B, Hepatitis C, and HIV/AIDS.

Dr. Richard E. Chaisson is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in epidemiology and in international health, both in the Johns Hopkins Bloomberg School of Public Health. His area of clinical expertise is infectious diseases, particularly tuberculosis and HIV/AIDS. Dr. Chaisson serves as the director of the Johns Hopkins University Center for Tuberculosis Research, and is the director of the Johns Hopkins Center for AIDS Research. He received his B.S. and M.D. degrees from the University of Massachusetts. He was an intern, resident, fellow and assistant professor of medicine at the University of California, San Francisco, prior to moving to Johns Hopkins. From 1988 to 1998 he was director of the Johns Hopkins AIDS Service, leading the inpatient Polk Service on Osler 8, a subacute care unit at Bayview Medical Center, and the outpatient Moore Clinic. His cohort studies of HIV and with his colleague Richard Moore made major contributions to understanding the treatment and outcomes of HIV disease. In 1991 he was appointed Medical Director of the Baltimore City Health Department Tuberculosis Clinic, establishing it as a leading program in TB control. He founded the Center for TB Research in 1998, which is one of the world's leading academic center for basic, clinical, applied, and epidemiologic investigations in TB and its control. Dr. Chaisson has conducted multiple trials of treatments and strategies to treat, prevent, and control TB, TB/HIV co-infection, and HIV. From 2002-2014 he led the Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE), and from 2011-2018 he was inaugural chair of the TB Transformative Science Group of the AIDS Clinical Trials Group. In 2022 he was awarded a $200 million cooperative agreement from USAID for SMART4TB, an international research consortium to study tools to end TB globally, working with partners from multiple institutions to implement research, strengthen local capacity, and drive policy change. Dr. Chaisson has been recognized with numerous honors, including the HIV/AIDS Warrior Award from AIDS Action Baltimore in 2022, a Lifetime Achievement Award from the International Union Against TB and Lung Disease North American Region in 2021, election to the Association of American Professors in 2016, the Champions of TB Control Award from the U.S. Agency for International Development (USAID) in 2014 and the American Thoracic Society's World Lung Health Award in 2006. Dr. Chaisson is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Severe Acute Respiratory Syndrome (SARS), and Sepsis.

Charles W. Flexner, M.D., is Professor of Medicine in the Divisions of Clinical Pharmacology and Infectious Diseases, and Professor of Pharmacology and Molecular Sciences in the Johns Hopkins University School of Medicine. He is also Professor of International Health in the Johns Hopkins University Bloomberg School of Public Health. Dr. Flexner is an expert on the basic and clinical pharmacology of drugs for HIV/AIDS and related infections, including viral hepatitis and tuberculosis. His scientific contributions include work on the important roles of pharmacokinetic enhancement, adherence, and dosing frequency in the long-term management of HIV/AIDS. He has published extensively on anti-infective drug transport and metabolism, and metabolic drug interactions. Dr. Flexner is currently the Chief Scientific Officer of the Institute for Clinical and Translational Research at Johns Hopkins. He also serves as Associate Vice-Chair for Academic Fellowship Programs in the Department of Medicine, and Associate Director of the Graduate Training Programs in Clinical Investigation of the Johns Hopkins University School of Medicine and Bloomberg School of Public Health. Dr. Flexner is the Principal Investigator of the Long-Acting Extended Release Antiretroviral Research Resource Program (LEAP), and Co-Principal Investigator of the Johns Hopkins University AIDS Clinical Trials Unit (ACTU) supported by the NIH. He served as President of the American Federation for Medical Research (AFMR) in 1999-2000, and was President of the AFMR Foundation from 2001-2002. He is a member of the editorial board of 10 scientific journals. He currently serves as a consultant to the Bill and Melinda Gates Foundation and the Clinton Health Access Initiative, and served as a consultant on FDA reform to the United States House of Representatives. Dr. Flexner is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS and Hepatitis.

Dr. Petros Karakousis is a Professor of Medicine at the Johns Hopkins University School of Medicine. He has joint appointments in Molecular Microbiology & Immunology and International Health at the Johns Hopkins Bloomberg School of Public Health. His areas of clinical expertise include infectious diseases and tuberculosis. Dr. Karakousis received his undergraduate degree in 1994 from the Johns Hopkins University and his medical degree in 1998 from Washington University School of Medicine in St. Louis. He completed residency training in internal medicine in 2001 at the Hospital of the University of Pennsylvania. After completing fellowship training in infectious diseases at Johns Hopkins, he joined the Department of Medicine faculty in 2005. His research interests include tuberculosis pathogenesis, Mycobacterium tuberculosis persistence and antibiotic tolerance, host-pathogen interactions and host-directed therapies. Dr. Karakousis was named a Fellow of the Infectious Diseases Society of America in 2010, and was elected to the American Society for Clinical Investigation in 2021. He has held numerous leadership positions, including in the Working Group on New TB Drugs of the Stop TB Partnership. He has served on the editorial board of various scientific journals and on numerous NIH study sections, and as a peer reviewer for many international government and private funding agencies. Dr. Karakousis is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Dr. Christine Durand, associate professor of medicine and oncology and member of the Johns Hopkins Kimmel Cancer Center, is involved in clinical and translational research focused on individuals infected with HIV and hepatitis C virus who require cancer and transplant therapies. Her current research efforts include looking at outcomes of hepatitis C treatment after solid organ transplant, the potential use of organs from HIV-infected donors for HIV-infected solid organ transplant candidates, and HIV cure strategies including bone marrow transplantation. Dr. Durand is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, Tissue Biopsy, and Nephrectomy.

Mark Sulkowski, MD, is a Professor of Medicine at the Johns Hopkins University School of Medicine and the Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. He also serves as the Medical Director of the Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology in the Department of Medicine and is the Senior Associate Dean for Clinical Trials. He received his MD from Temple University School of Medicine, Philadelphia, PA (1992), pursued training in Internal Medicine at Duke University School of Medicine, Durham, NC (1995) and completed his Fellowship in Infectious Diseases (1998) at the Johns Hopkins University School of Medicine. Prof. Sulkowski has been the principal investigator for more than 120 clinical trials related to the management of viral hepatitis B and C in persons with and without HIV co-infection. He was the global principal investigator for more than a dozen trials, including the largest clinical trial of agents for the treatment of hepatitis C (New England Journal of Medicine, 2009) and the vanguard study of combination therapy with direct inhibitors of the HCV NS5A and NS5B non-structural proteins (New England Journal of Medicine, 2014). He is the past-chair of the Hepatitis Transformative Sciences Group of the National Institute of Health-funded adult AIDS Clinical Trials Group (ACTG) where he led translational studies of liver disease, namely hepatitis B and C virus. He is an elected member of the American Society for Clinical Investigation (2011) and the American Association of Physicians (2017). Prof. Sulkowski is a member of numerous professional societies including the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and the Infectious Diseases Society of America (IDSA). With more than 300 peer-reviewed articles, he is widely published with works in Annals of Internal Medicine, New England Journal of Medicine, JAMA, Clinical Infectious Diseases, Journal of Hepatology, and Hepatology. In 2017, 2018 and 2019, he was named as a Highly Cited Researcher (Clarivate Analytics) defined as the being in the top 1% of global researchers in 21 fields of the sciences and social sciences based on the number of citations for papers. As an invited lecturer, he has been frequently invited to present at major national and international medical congresses and has educated learners in more than 25 countries. Dr. Sulkowski is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Hepatitis B.

Dr. Patricia Andrea Barditch-Crovo is a clinical associate at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include HIV/AIDS and infectious disease. Dr. Barditch-Crovo earned her M.D. from the University of Maryland School of Medicine. She completed her residency at the University of Maryland Medical Center and performed a fellowship in clinical pharmacology at Johns Hopkins. Dr. Barditch is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome.

Dr. Christie Basseth is a clinical associate at the Johns Hopkins University School of Medicine. Her area of clinical expertise is infectious disease. Dr. Basseth earned her M.D. from the University of Medicine and Dentistry of New Jersey. She completed her residency at Montefiore Medical Center and performed a fellowship at New York-Presbyterian Hospital/Columbia. Dr. Basseth is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are Myelitis, AIDS Dementia Complex, AIDS Dysmorphic Syndrome, and HIV/AIDS.